Liguori Tácia Tavares Aquinas, Liguori Gabriel Romero, van Dongen Joris A, Moreira Luiz Felipe Pinho, Harmsen Martin Conrad
Instituto do Coração (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.
University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands.
Biomed Mater. 2021 Feb 24;16(2):025022. doi: 10.1088/1748-605X/abcff9.
The administration of trophic factors (TFs) released by mesenchymal stromal cells (MSCs) as therapy for cardiovascular diseases requires a delivery vehicle capable of binding and releasing the TF in a sustained manner. We hypothesized that hydrogels derived from cardiac decellularized extracellular matrix (cardiac dECM) bind MSC secretome-derived TF and release these in a sustained fashion. Pig-derived ventricular tissue was decellularized, milled to powder, digested, and assembled as a hydrogel upon warming at 37 °C. The conditioned medium (CMed) of adipose tissue-derived stromal cells (ASC) was collected, concentrated, and incorporated into the hydrogel at 1×, 10×, and 100× the original concentration. The release of 11 ASC-secreted factors (angiopoietin-1, angiopoietin-2, fibroblast growth factor-1, hepatocyte growth factor, platelet-derived growth factor-AA, vascular endothelial growth factor, interleukin-1β, interleukin-6, interleukin-8, CCL2, and matrix metalloproteinase-1) from hydrogels was immune assessed. Bioactivity was determined by endothelial cell proliferation, function, and assessment of endothelial mesenchymal transition. We showed that dECM hydrogels could be loaded with human ASC-secreted TFs, which are released in a sustained manner for several days subsequently. Different trophic factors had different release kinetics, which correlates with the initial concentration of CMed in the hydrogel. We observed that the more concentrated was the hydrogel, the more inflammation-related cytokines, and the less pro-regenerative TFs were released. Finally, we showed that the factors secreted by the hydrogel are biologically active as these influence cell behavior. The use of dECM hydrogels as a platform to bind and release paracrine factors secreted by (mesenchymal) cells is a potential alternative in the context of cardiovascular regeneration.
施用间充质基质细胞(MSC)释放的营养因子(TF)作为心血管疾病的治疗方法,需要一种能够持续结合和释放TF的递送载体。我们假设源自心脏脱细胞细胞外基质(心脏dECM)的水凝胶能够结合MSC分泌组衍生的TF并持续释放这些因子。将猪源心室组织进行脱细胞处理,研磨成粉末,消化后在37℃加热时组装成水凝胶。收集脂肪组织来源的基质细胞(ASC)的条件培养基(CMed),浓缩后以原始浓度的1倍、10倍和100倍掺入水凝胶中。通过免疫评估从水凝胶中释放的11种ASC分泌因子(血管生成素-1、血管生成素-2、成纤维细胞生长因子-1、肝细胞生长因子、血小板衍生生长因子-AA、血管内皮生长因子、白细胞介素-1β、白细胞介素-6、白细胞介素-8、CCL2和基质金属蛋白酶-1)。通过内皮细胞增殖、功能以及内皮间充质转化评估来确定生物活性。我们表明,dECM水凝胶可以负载人ASC分泌的TF,随后这些TF会持续释放数天。不同的营养因子具有不同的释放动力学,这与水凝胶中CMed的初始浓度相关。我们观察到,水凝胶浓度越高,释放的炎症相关细胞因子越多,而促再生TF越少。最后,我们表明水凝胶分泌的因子具有生物活性,因为它们会影响细胞行为。在心血管再生的背景下,使用dECM水凝胶作为结合和释放(间充质)细胞分泌的旁分泌因子的平台是一种潜在的替代方法。